Literature DB >> 16389554

Expression of CD180, a toll-like receptor homologue, is up-regulated in children with Kawasaki disease.

Miyoko Imayoshi1, Shuichi Yamamoto, Mamie Watanabe, Shinji Nishimura, Katsuya Tashiro, Masafumi Zaitsu, Hakaru Tasaki, Masao Kimoto, Yuhei Hamasaki, Eiichi Ishii.   

Abstract

Kawasaki disease (KD) is an acute febrile illness in childhood characterized by the formation of aneurysms in coronary arteries. It is believed that KD is caused by infectious agents because of its epidemic waves and high incidence of familial occurrence. Because an increase in the levels and dysfunction of B cells in peripheral blood was reported in KD, we investigated the expression of cluster of differentiation 180 (CD180), a toll-like receptor homologue, in the B cells of children with KD, and in those with bacterial or viral infections. The percentages of CD180 positive B cells were significantly higher in children with KD or viral infections than in those with bacterial infections or in healthy controls. When the expression levels of CD180 were compared by using the mean fluorescent intensity ratio of patients to healthy controls, the level of CD180 expression was also significantly up-regulated in children with KD or viral infections. To clarify the effect of viral infection on the expression of CD180, B cells were stimulated with poly inosinic-cytidyric acid [poly(IC)], a synthetic double-stranded RNA. Poly(IC) clearly enhanced CD180 expression in B cells in vitro, both at the protein and messenger RNA levels. These results suggest that similar mechanisms may be involved in the up-regulation of B cell CD180 expression in patients with either KD or viral infections.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16389554     DOI: 10.1007/s00109-005-0010-8

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  21 in total

1.  The role of bacterial lipopolysaccharide-bound neutrophils in the pathogenesis of Kawasaki disease.

Authors:  S Takeshita; K Nakatani; H Kawase; S Seki; M Yamamoto; I Sekine; S Yoshioka
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

2.  Clinical role for a superantigen in Yersinia pseudotuberculosis infection.

Authors:  J Abe; M Onimaru; S Matsumoto; S Noma; K Baba; Y Ito; T Kohsaka; T Takeda
Journal:  J Clin Invest       Date:  1997-04-15       Impact factor: 14.808

3.  Fate of coronary arterial aneurysms in Kawasaki disease.

Authors:  A Suzuki; T Kamiya; Y Arakaki; Y Kinoshita; K Kimura
Journal:  Am J Cardiol       Date:  1994-10-15       Impact factor: 2.778

4.  Polyclonal expansion of TCRBV2- and TCRBV6-bearing T cells in patients with Kawasaki disease.

Authors:  T Yoshioka; T Matsutani; S Iwagami; T Toyosaki-Maeda; T Yutsudo; Y Tsuruta; H Suzuki; S Uemura; T Takeuchi; M Koike; R Suzuki
Journal:  Immunology       Date:  1999-03       Impact factor: 7.397

5.  Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105.

Authors:  Senad Divanovic; Aurelien Trompette; Sowsan F Atabani; Rajat Madan; Douglas T Golenbock; Alberto Visintin; Robert W Finberg; Alexander Tarakhovsky; Stefanie N Vogel; Yasmine Belkaid; Evelyn A Kurt-Jones; Christopher L Karp
Journal:  Nat Immunol       Date:  2005-04-24       Impact factor: 25.606

6.  Detection of antigen in bronchial epithelium and macrophages in acute Kawasaki disease by use of synthetic antibody.

Authors:  Anne H Rowley; Susan C Baker; Stanford T Shulman; Francesca L Garcia; Judith A Guzman-Cottrill; Pauline Chou; Masaru Terai; Tomisaku Kawasaki; Mitra B Kalelkar; Susan E Crawford
Journal:  J Infect Dis       Date:  2004-07-16       Impact factor: 5.226

7.  Mouse MD-1, a molecule that is physically associated with RP105 and positively regulates its expression.

Authors:  K Miyake; R Shimazu; J Kondo; T Niki; S Akashi; H Ogata; Y Yamashita; Y Miura; M Kimoto
Journal:  J Immunol       Date:  1998-08-01       Impact factor: 5.422

Review 8.  Probable role of Streptococcus pyogenes in Kawasaki disease.

Authors:  T Akiyama; K Yashiro
Journal:  Eur J Pediatr       Date:  1993-02       Impact factor: 3.183

9.  Expression of the cytoplasmic tail of LMP1 in mice induces hyperactivation of B lymphocytes and disordered lymphoid architecture.

Authors:  Laura L Stunz; Lisa K Busch; Melissa E Munroe; Curt D Sigmund; Lorraine T Tygrett; Thomas J Waldschmidt; Gail A Bishop
Journal:  Immunity       Date:  2004-08       Impact factor: 31.745

10.  Murine B cell proliferation and protection from apoptosis with an antibody against a 105-kD molecule: unresponsiveness of X-linked immunodeficient B cells.

Authors:  K Miyake; Y Yamashita; Y Hitoshi; K Takatsu; M Kimoto
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307

View more
  5 in total

1.  Gene transcript abundance profiles distinguish Kawasaki disease from adenovirus infection.

Authors:  Stephen J Popper; Virginia E Watson; Chisato Shimizu; John T Kanegaye; Jane C Burns; David A Relman
Journal:  J Infect Dis       Date:  2009-08-15       Impact factor: 5.226

2.  A diagnostic algorithm combining clinical and molecular data distinguishes Kawasaki disease from other febrile illnesses.

Authors:  Xuefeng B Ling; Kenneth Lau; John T Kanegaye; Zheng Pan; Sihua Peng; Jun Ji; Gigi Liu; Yuichiro Sato; Tom T S Yu; John C Whitin; James Schilling; Jane C Burns; Harvey J Cohen
Journal:  BMC Med       Date:  2011-12-06       Impact factor: 8.775

3.  Analysis of lung transcriptome in calves infected with Bovine Respiratory Syncytial Virus and treated with antiviral and/or cyclooxygenase inhibitor.

Authors:  Maxim Lebedev; Heather A McEligot; Victoria N Mutua; Paul Walsh; Francisco R Carvallo Chaigneau; Laurel J Gershwin
Journal:  PLoS One       Date:  2021-02-18       Impact factor: 3.240

4.  A Model of Left Ventricular Dysfunction Complicated by CAWS Arteritis in DBA/2 Mice.

Authors:  Naoto Hirata; Ken-Ichi Ishibashi; Tatsuya Usui; Jiro Yoshioka; Satoru Hata; Yoshiyuki Adachi; Noriko Nagi-Miura; Shin Ohta; Naohito Ohno
Journal:  Int J Vasc Med       Date:  2012-07-08

5.  Effects of 17β-Estradiol on Monocyte/Macrophage Response to Staphylococcus aureus: An In Vitro Study.

Authors:  Clarissa Leal Silva E Souza; Camila Dutra Barbosa; Hanna I L N Coelho; Manoel N Santos Júnior; Elaine Novaes Barbosa; Éllunny Chaves Queiroz; Mauro Fernandes Teles; Déborah Cruz Dos Santos; Rafaela Souza Bittencourt; Telma de Jesus Soares; Márcio Vasconcelos Oliveira; Jorge Timenetsky; Guilherme Barreto Campos; Lucas Miranda Marques
Journal:  Front Cell Infect Microbiol       Date:  2021-07-14       Impact factor: 5.293

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.